Akil, Giahida D.
HRN: 22-84-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/19/2023
04/19/2023
IV
500mg
Now
Prophylaxis, For Stat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes